What do systematic reviews say?

Early vs deferred AST

• Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 285 participants
  Moderate